Acorah Software Products - Accounts Production16.7.461falsetruefalsetrueNo description of principal activity12 August 202431 March 202531 March 202515890963Dr Maria Mouyisiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure158909632024-08-11158909632025-03-31158909632024-08-122025-03-3115890963frs-core:CurrentFinancialInstruments2025-03-3115890963frs-bus:PrivateLimitedCompanyLtd2024-08-122025-03-3115890963frs-bus:FilletedAccounts2024-08-122025-03-3115890963frs-bus:Micro-entities2024-08-122025-03-3115890963frs-bus:AuditExempt-NoAccountantsReport2024-08-122025-03-3115890963frs-bus:Director12024-08-122025-03-31
Registered number: 15890963
Mosaic Medicine Limited
Unaudited Financial Statements
For the Period 12 August 2024 to 31 March 2025
Sharpe Medical Accounting Ltd
Mosaic Medicine Limited
Balance Sheet
As At 31 March 2025
Balance Sheet
Registered number: 15890963
31 March 2025
£
Current assets
1,871
Creditors: Amounts Falling Due Within One Year
(968)
NET CURRENT ASSETS
903
TOTAL ASSETS LESS CURRENT LIABILITIES
903
Accruals and deferred income
(840)
NET ASSETS
63
CAPITAL AND RESERVES
63
Notes
1.General Information
Mosaic Medicine Limited is a private company, limited by shares, incorporated in England & Wales, registered number 15890963. The registered office is Normanby Gateway, Lysaghts Way, Scunthorpe, North Lincolnshire, DN15 9YG.
2.Average Number of Employees
Average number of employees, including directors, during the period was:1 1
1
Page 0
Page 1
Mosaic Medicine Limited
Balance Sheet (continued)
As At 31 March 2025
For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.